GlassScriptPhysician profile
Amanda Lee Baker
NPI 1750957338
$1,570.32
in general payments reported to CMS, 2019-2025
16 companies · $537 in 2025
The $537 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.92 · 2022: $577 · 2023: $227 · 2024: $136 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $351.07 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $294.05 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $193.22 | 2021-2025 | Zepbound, Mounjaro, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $168.94 | 2022 | |
| Grt US Holding, INC. | $113.37 | 2022 | |
| Abbvie INC. | $88.04 | 2021-2023 | |
| Pfizer INC. | $78.30 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.23 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.78 | 2022 | |
| Idorsia Pharmaceuticals US INC | $44.76 | 2022-2023 | Quviviq |
| Horizon Therapeutics Plc | $35.99 | 2022 | |
| Amgen INC. | $24.38 | 2022 | |
| Boston Scientific Corporation | $19.13 | 2022 | |
| Hologic Sales and Service, LLC | $17.45 | 2024 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $15.71 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.